@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-LLQC3G41-Z
  skos:prefLabel "Phosphoprotéines"@fr, "Phosphoproteins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-DPL2Z27N-2 .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HH6T9P1K-W
  skos:prefLabel "Nuclear Proteins"@en, "Protéines nucléaires"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-DPL2Z27N-2 .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T32PRJLW-G
  skos:prefLabel "Protéines des groupes de complémentation de l'anémie de Fanconi"@fr, "Fanconi Anemia Complementation Group Proteins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-DPL2Z27N-2 .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DPL2Z27N-2
  mesh:allowableQualifier jvr:-NHL3D2X0-S, jvr:-T9HQD7ST-J, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-G30ZJ446-J, jvr:-G7KXQWSR-5, jvr:-Z9TSGBXH-4, jvr:-CJXMKG5Q-F, jvr:-HQRFT0C6-B, jvr:-FWD2BGQ0-9, jvr:-Q3979798-W, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-W6SQV79N-S, jvr:-THHNVC7V-3, jvr:-NFTHND7Q-8, jvr:-WZF2ZR3L-B, jvr:-TJHVZCRZ-0, jvr:-L6C0XPHT-4, jvr:-S0CS1X5R-5, jvr:-WK5F724J-1, jvr:-XV06LPML-W, jvr:-SBNWSM1T-R, jvr:-D0F21513-5, jvr:-NKM836P1-M, jvr:-N2WP45CN-V, jvr:-R3QWLHRG-V, jvr:-R0ZCQ8X6-J, jvr:-H7K65Q8S-Z, jvr:-T2TS0S41-N ;
  skos:broader jvr:-T32PRJLW-G, jvr:-HH6T9P1K-W, jvr:-LLQC3G41-Z ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D052236> ;
  skos:altLabel "Protéine du groupe D-2 de l'anémie de Fanconi"@fr, "Protéine du groupe D2 de la maladie de Fanconi"@fr, "Protéine du groupe D-2 de la maladie de Fanconi"@fr, "Protéine FANCD2"@fr, "Fanconi Anemia Group D2 Protein"@en, "Fanconi Anemia Group D2 Complementing Protein"@en, "Protéine FANC-D2"@fr, "Protéine FANC-D-2"@fr, "FANCD2 Protein"@en, "Protéine du groupe D2 de l'anémie de Fanconi"@fr ;
  skos:inScheme jvr: ;
  dc:established "2006-01-01"^^xsd:date ;
  skos:prefLabel "Fanconi Anemia Complementation Group D2 Protein"@en, "Protéine du groupe de complémentation D2 de l'anémie de Fanconi"@fr ;
  dc:modified "2009-07-20"^^xsd:date ;
  skos:definition "A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to IONIZING RADIATION it can undergo PHOSPHORYLATION by ataxia telangiectasia mutated protein. Modified FANCD2 interacts with BRCA2 PROTEIN in a stable complex with CHROMATIN, and it is involved in DNA REPAIR by homologous RECOMBINATION."@en ;
  a mesh:Descriptor, skos:Concept ;
  dc:created "2005-06-30"^^xsd:date .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .